March 4, 2022
308,762
8,971
2,045
3.57%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
24:37Now PlayingOr is it many more that that? If you would like John’s text books, (it is free to download the PDFs)
Link to free download of my 2 textbooks
Physiology book in hard copy
140 million Americans have had coronavirus
Nationwide COVID-19 Infection-Induced Antibody Seroprevalence (Commercial laboratories)
58 % up to 17 years, have antibodies infection
Last data, 72,000 blood samples taken in January
Percentage, United States, resolving or past infection with SARS-CoV-2,
but not how much antibody is present,
do not necessarily indicate the percentage of people with sufficient antibody to protect against reinfection
These percentages do not include people who have been vaccinated against SARS-CoV-2 and have no history of infection.
Results directly from paper
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
Nationwide COVID-19 Infection- and Vaccination-Induced Antibody Seroprevalence (Blood donations)
Percentage, 16 years and older, developed antibodies against SARS-CoV-2 from vaccination or infection.
December 2021
Australia
UK, ONS
Week ending 19 February
3.84% in England (1 in 25 people)
3.23% in Wales (1 in 30 people)
7.23% in Northern Ireland (1 in 14 people)
4.57% in Scotland (1 in 20 people)
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.